Research & Development World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Imaging
    • Nanotechnology
    • Semiconductors
  • Controlled Environments
    • Cleanrooms
    • Graphene
    • Lasers
    • Regulations/Standards
    • Sensors
  • Scientific Computing
    • Big Data
    • HPC/Supercomputing
    • Informatics
    • Security
    • Software
  • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
    • R&D 100 Conference
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • 2020 Funding Forecast
  • COVID-19

Using Big Data to Understand Immune System Responses

By Norwegian University of Science and Technology | January 25, 2017

Numerous researchers around the globe have begun to use the gene editing tool CRISPR to understand human biology. One of them is Associate Professor Richard Kandasamy at the Norwegian University of Science and Technology's (NTNU) Centre of Molecular Inflammation Research (CEMIR). Kandasamy is working on understanding inflammatory reactions that occur in many diseases.

Using large amounts of data, his research reveals what happens minute-by-minute when the immune system responds to a virus. The results of his team's research were recently published in the respected online journal Systems Biology and Applications.

When the flu or any other virus attacks the body, it has to react with lightning speed.

"It's not like defense cells are just sitting around waiting in some corner of the body to gobble up viruses - and boom, it's all taken care of," says Kandasamy.

As Kandasamy explains, "What happens inside the defense cells is a very comprehensive step-by-step reaction. Signals are sent to the nucleus to initiate a production of new proteins that will take part in the inflammatory reaction and that the cell will use to destroy the virus. This all takes some time. But even a tiny chemical modification of proteins in the cell also enables the cell to start reacting super quickly."

He and his team can map these reactions in extreme detail from the moment a virus infects a cell. By frequently repeating the mapping process in the hours after infection, they can create a detailed map of the cell's reactions.

Most scientists who are working on CRISPR research either proceed by analysing one gene at a time, or upwards of 20,000 genes at a time. Kandasamy uses both approaches.

He also uses large computing systems to analyse this complex dataset. This approach of combining modern technologies and mapping reactions minute-by-minute is one of the unique approaches his research group uses to understand reactions in the cell.

Kandasamy came to NTNU through the Onsager Fellowship programme, which is designed to recruit some of the most talented international young researchers to the university. Just before Christmas, Kandasamy was awarded a generous grant for independent research from the Research Council of Norway's FRIPRO programme for promising young researchers.

Related Articles Read More >

IDMO, of China, joins Repositive Cancer Model network, expanding model database
Thermo Fisher Scientific releases SARS-CoV-2 Optimized Precipitation Reagent and Enrichment Kits for isolating virus particles
Lawrence Livermore National Lab and UK company to collaborate on universal coronavirus vaccine
ZEISS announces collaborative research partnership with Max Planck Florida Institute for Neuroscience

Need R&D World news in a minute?

We Deliver!
R&D World Enewsletters get you caught up on all the mission critical news you need in research and development. Sign up today.
Enews Signup
Tweets by @RandDWorld

R&D World Digital Issues

February 2020 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R& magazine today.

Research & Development World
  • Subscribe to R&D World Magazine
  • Enews Sign Up
  • Contact Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • 2020 Global Funding Forecast

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search R&D World

  • Home Page
  • Topics
    • Aerospace
    • Archeology
    • Automotive
    • Biotech
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Market Pulse
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Battery Technology
    • Imaging
    • Nanotechnology
    • Semiconductors
  • Controlled Environments
    • Cleanrooms
    • Graphene
    • Lasers
    • Regulations/Standards
    • Sensors
  • Scientific Computing
    • Big Data
    • HPC/Supercomputing
    • Informatics
    • Security
    • Software
  • R&D 100 Awards
    • 2020 Winners
    • Winner Archive
    • R&D 100 Conference
  • Resources
    • Digital Issues
    • Podcasts
    • Subscribe
  • 2020 Funding Forecast
  • COVID-19